Search

everythinglearnresearchcommunity

for

Search:↓

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Finasteride helps reduce heart issues and improves heart function.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Human hair contains diverse proteins, including keratins and histones, which could help assess hair health and aging.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

The nanohybrid system significantly improved wound healing and showed strong antibacterial activity.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

Finasteride-loaded nanoparticles may help treat alopecia.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

New genes found linked to balding, may help develop future treatments.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

LLLT promotes hair growth and improves hair density safely in men and women.

Lymphatic vessels are essential for hair follicle growth and skin regeneration.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Genetic variations affecting skin structure play a key role in severe acne.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.